Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Prepaid Assets (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Prepaid Assets for 7 consecutive years, with $23.5 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 14.34% to $23.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.5 million through Dec 2025, down 14.34% year-over-year, with the annual reading at $23.5 million for FY2025, 14.34% down from the prior year.
  • Prepaid Assets for Q4 2025 was $23.5 million at Beam Therapeutics, roughly flat from $23.6 million in the prior quarter.
  • The five-year high for Prepaid Assets was $27.7 million in Q1 2025, with the low at $7.4 million in Q4 2021.
  • Average Prepaid Assets over 5 years is $19.3 million, with a median of $21.2 million recorded in 2023.
  • The sharpest move saw Prepaid Assets surged 100.57% in 2022, then fell 17.88% in 2024.
  • Over 5 years, Prepaid Assets stood at $7.4 million in 2021, then soared by 100.57% to $14.8 million in 2022, then surged by 43.39% to $21.2 million in 2023, then increased by 29.49% to $27.4 million in 2024, then decreased by 14.34% to $23.5 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $23.5 million, $23.6 million, and $25.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.